ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

JJ Kiladjian; FF Marin; HK Al-Ali; A Alvarez-Larran; E Beggiato; M Bieniaszewska; M Breccia; V Buxhofer-Ausch; O Cerna; AM Crisan; C Danaila; V De Stefano; K Dohner; V Empson; JG Tybor; M Griesshammer; S Grosicki; P Guglielmelli; VGG Sr; F Heidel; A Illes; C James; S Koschmieder; K Maria-Theresa; K Krejcy; MC Lazaroiu; J Mayer; Z Nagy; F Palandri; V Pappa; A Reiter; T Sacha; S Schlager; SU Schmidt; E Terpos; C Tomuleasa; JM Torregrosa; M Unger; Albert Wölfler; B Xicoy; C Klade

doi:10.1182/blood-2024-199028

ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

JJ Kiladjian
, FF Marin
, HK Al-Ali
, A Alvarez-Larran
, E Beggiato
, M Bieniaszewska
, M Breccia
, V Buxhofer-Ausch
, O Cerna
, AM Crisan
, C Danaila
, V De Stefano
, K Dohner
, V Empson
, JG Tybor
, M Griesshammer
, S Grosicki
, P Guglielmelli
, VGG Sr
, F Heidel

A Illes, C James, S Koschmieder, K Maria-Theresa, K Krejcy, MC Lazaroiu, J Mayer, Z Nagy, F Palandri, V Pappa, A Reiter, T Sacha, S Schlager, SU Schmidt, E Terpos, C Tomuleasa, JM Torregrosa, M Unger, Albert Wölfler, B Xicoy, C Klade

Klinische Abteilung für Hämatologie

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

Originalsprache	Englisch
Seitenumfang	3
Fachzeitschrift	Blood
Jahrgang	144
DOIs	https://doi.org/10.1182/blood-2024-199028
Publikationsstatus	Veröffentlicht - 2024
Veranstaltung	66th Annual Meeting of the American Society of Hematology - Orlando, USA/Vereinigte Staaten Dauer: 7 Dez. 2024 → 10 Dez. 2024

Wissenschaftszweige

301 Medizinisch-theoretische Wissenschaften, Pharmazie
302 Klinische Medizin

Zugriff auf Dokument

10.1182/blood-2024-199028

Andere Dateien und Links

Web of Science

Dieses zitieren

Kiladjian, JJ., Marin, FF., Al-Ali, HK., Alvarez-Larran, A., Beggiato, E., Bieniaszewska, M., Breccia, M., Buxhofer-Ausch, V., Cerna, O., Crisan, AM., Danaila, C., De Stefano, V., Dohner, K., Empson, V., Tybor, JG., Griesshammer, M., Grosicki, S., Guglielmelli, P., Sr, VGG., ... Klade, C. (2024). ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options. Blood, 144. https://doi.org/10.1182/blood-2024-199028

@article{1d694af8cca14b488a32917bd82a93d9,

title = "ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options",

author = "JJ Kiladjian and FF Marin and HK Al-Ali and A Alvarez-Larran and E Beggiato and M Bieniaszewska and M Breccia and V Buxhofer-Ausch and O Cerna and AM Crisan and C Danaila and \{De Stefano\}, V and K Dohner and V Empson and JG Tybor and M Griesshammer and S Grosicki and P Guglielmelli and VGG Sr and F Heidel and A Illes and C James and S Koschmieder and K Maria-Theresa and K Krejcy and MC Lazaroiu and J Mayer and Z Nagy and F Palandri and V Pappa and A Reiter and T Sacha and S Schlager and SU Schmidt and E Terpos and C Tomuleasa and JM Torregrosa and M Unger and Albert W{\"o}lfler and B Xicoy and C Klade",

year = "2024",

doi = "10.1182/blood-2024-199028",

language = "English",

volume = "144",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

note = "66th Annual Meeting of the American Society of Hematology ; Conference date: 07-12-2024 Through 10-12-2024",

}

Kiladjian, JJ, Marin, FF, Al-Ali, HK, Alvarez-Larran, A, Beggiato, E, Bieniaszewska, M, Breccia, M, Buxhofer-Ausch, V, Cerna, O, Crisan, AM, Danaila, C, De Stefano, V, Dohner, K, Empson, V, Tybor, JG, Griesshammer, M, Grosicki, S, Guglielmelli, P, Sr, VGG, Heidel, F, Illes, A, James, C, Koschmieder, S, Maria-Theresa, K, Krejcy, K, Lazaroiu, MC, Mayer, J, Nagy, Z, Palandri, F, Pappa, V, Reiter, A, Sacha, T, Schlager, S, Schmidt, SU, Terpos, E, Tomuleasa, C, Torregrosa, JM, Unger, M, Wölfler, A, Xicoy, B & Klade, C 2024, 'ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options', Blood, Jg. 144. https://doi.org/10.1182/blood-2024-199028

TY - JOUR

T1 - ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

AU - Kiladjian, JJ

AU - Marin, FF

AU - Al-Ali, HK

AU - Alvarez-Larran, A

AU - Beggiato, E

AU - Bieniaszewska, M

AU - Breccia, M

AU - Buxhofer-Ausch, V

AU - Cerna, O

AU - Crisan, AM

AU - Danaila, C

AU - De Stefano, V

AU - Dohner, K

AU - Empson, V

AU - Tybor, JG

AU - Griesshammer, M

AU - Grosicki, S

AU - Guglielmelli, P

AU - Sr, VGG

AU - Heidel, F

AU - Illes, A

AU - James, C

AU - Koschmieder, S

AU - Maria-Theresa, K

AU - Krejcy, K

AU - Lazaroiu, MC

AU - Mayer, J

AU - Nagy, Z

AU - Palandri, F

AU - Pappa, V

AU - Reiter, A

AU - Sacha, T

AU - Schlager, S

AU - Schmidt, SU

AU - Terpos, E

AU - Tomuleasa, C

AU - Torregrosa, JM

AU - Unger, M

AU - Wölfler, Albert

AU - Xicoy, B

AU - Klade, C

PY - 2024

Y1 - 2024

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001412545100031

U2 - 10.1182/blood-2024-199028

DO - 10.1182/blood-2024-199028

M3 - Conference abstract

SN - 0006-4971

VL - 144

JO - Blood

JF - Blood

T2 - 66th Annual Meeting of the American Society of Hematology

Y2 - 7 December 2024 through 10 December 2024

ER -